BioPlus pharmacy specialist (BioPlus), one of the nation's leading specialty pharmacy, continue to go through periods of growth and has brought new ships senior vice president, Elvin Montanez, Pharm d., to support the expansion of the company. Dr. Montanez will contribute to the development and implementation of growth strategy in BioPlus.
"I have a passion for bringing value to our customers through the pharmaceutical benefits, superior service, and innovation. The demand for cost effective, quality of medical care has never been greater. I am proud to join an organization that shared mission is to improve the way an experienced health and conveyed, "stated Dr. Montanez.
Dr. Montanez has 20 years of leadership experience, as well as healthcare Executive a strong background in pharmaceutical services. Dr. Montanez received her Doctor of Pharmacy degree, magna cum laude, from the University of Florida, Gainesville. He is a member of the Board of Review and CHAP has a vast knowledge of accreditation standards, as well as being a member of various professional organizations, including the American Society of hospital pharmacists and home infusion Association nationwide.
"Dr. Montanez brings a comprehensive background in management, in infusion therapy and Specialty Pharmacy areas. He has a strategic relationship in medical care-pharmaceutical, pharmacy, and mandatory. His leadership will be invaluable in the development of the clinical program, a special infusion pharmacy operations, and multi-site management, "said Dr. Stephen Vogt, President and CEO of BioPlus.
BioPlus is owned by pharmacists, VIPPS accredited, a pharmacy infusion of special National Service provides high-touch and special medicines to patients with chronic diseases such as hepatitis, bleeding disorders, cancer, and other conditions. Licensed in all 50 States, BioPlus is one of the largest independent specialty pharmacies. Accredited by the Accreditation Program (CHAP) public health, patients may contact the pharmacy toll free at 1-888-514-8082.

Recent Comments